08/04/2025 5:49 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2025 5:24 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/07/2025 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2025 5:05 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/13/2025 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2025 7:31 AM | Innate Pharma (Subject) Innate Pharma SA (Subject) NOVO NORDISK A S (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2025 5:11 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2025 5:17 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/19/2025 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2025 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for IPHYF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter.
|
05/13/2025 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2025 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2025 5:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2025 10:31 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2025 8:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
04/29/2025 5:48 PM | Innate Pharma (Subject) Innate Pharma SA (Subject) Sanofi (Filed by) Sanofi (Filed by)
| Form SCHEDULE 13G/A | |
04/29/2025 2:02 PM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/28/2025 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2025 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2025 7:28 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2025 5:05 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2025 5:07 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2025 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025 6:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2025 6:07 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2025 6:23 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2025 6:24 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/27/2025 5:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 5:16 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/27/2025 6:57 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/21/2025 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2025 7:16 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/10/2025 5:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2024 6:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/09/2024 5:04 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2024 5:02 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/19/2024 5:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why (Ad) Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund.
It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you."
This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight. Click here for the full story. |
11/08/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2024 6:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 5:11 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 5:15 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2024 5:15 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2024 5:07 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024 3:00 PM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/09/2024 5:13 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024 5:10 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024 5:11 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |